Dutch 'Lack Vision, Courage'

AMSTERDAM—The Dutch space program, once a leader in scientific research on many fronts, has been weakened to the point of ineffectiveness, according to scientists and aerospace industry officials. The chief cause, they say, is a reluctance by the government to adopt a long-range plan and commit the resources necessary to achieve it. "The Dutch government lacks vision and courage," said Karel Wakker, professor of space technology at the Technical University in Delft. "In most European count

Written byHans Friedeman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

"The Dutch government lacks vision and courage," said Karel Wakker, professor of space technology at the Technical University in Delft. "In most European countries, governments stimulate their space programs on a large scale. The Dutch government, however, is carrying out a policy characterized by insufficient budgets, dispersed over too many projects."

Wakker and others argue that the government needs to play a more active role in the European Space Agency (ESA). In addition, they note, responsibility for the country's space program is splintered among several ministries, including economic affairs, transportation, health and defense.

"The problem is that each department is waiting for the decisions of the other," said Wakker. "None of them makes a decision with any degree of scope. The outcome is that the Netherlands takes part in many ESA projects, but not beyond the 4.5 to 5 percent that corresponds to Holland's share of the total gross national ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies